Third Time’s A Charm? Endo’s Injectable Testosterone Finally Ready For Advisory Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA says reports of oil embolism and anaphylactic reations with other testosterone injectables also will be part of the discussion during an April 18 meeting of the Reproductive Health Drugs and Drug Safety and Risk Management advisory committees to review Aveed (testosterone undecanoate).